Skip to main content Help with accessibility Skip to main navigation

Cannabis Extract oromucosal spray (Sativex®)

CCG Approval Status:

Date Added: 27 - Feb - 2020
Body System:
Amber retained

For the symptomatic treatment of moderate to severe spasticity in adult patients with multiple sclerosis when other pharmacological treatments for spasticity are ineffective.